BGU researchers are on the verge of a breakthrough that is bringing the world closer to a cure for diabetes.
Researchers at BGU’s Clinical Islet Laboratory are pursuing three major goals: transplants and new drugs, gene therapy, and the creation of a “transgenic” mouse that can tolerate human material for experimentation. They’re working on new drugs based on the alpha-1-antitrypsin (AAT) protein that reduces inflammation. Recent clinical trials demonstrated that infusion of AAT in recently diagnosed type 1 diabetes patients could eventually eliminate the need for insulin injections. A new clinical trial is under way to evaluate AAT dosing levels and duration.
Diabetes Videossee all videos
Diabetes Newssee all news
Bedouin Women Face Obstacles to Access Healthcare
Interviews conducted by Haneen Shibli, a researcher at BGU, shed light on the difficulties Bedouin women run into when seeking medical care in Israel.
New Advice for Type 2 Diabetics: Drink Wine
A BGU study says that those with the disease might experience benefits if they drink wine in moderation.
A Better Way to Predict Diabetes Remission
BGU develops an advanced scoring method to help doctors predict type 2 remission following bariatric surgery.